• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锂诱导自噬特异性清除依赖种子的 tau 聚集物。

Strain-specific clearance of seed-dependent tau aggregation by lithium-induced autophagy.

机构信息

Department of Diagnosis, Prevention and Treatment of Dementia, Graduate School of Medicine, Juntendo University, Tokyo, Japan.

Department of Diagnosis, Prevention and Treatment of Dementia, Graduate School of Medicine, Juntendo University, Tokyo, Japan; Department of Neurology, Graduate School of Medicine, Juntendo University, Tokyo, Japan.

出版信息

Biochem Biophys Res Commun. 2021 Mar 5;543:65-71. doi: 10.1016/j.bbrc.2020.12.113. Epub 2021 Jan 28.

DOI:10.1016/j.bbrc.2020.12.113
PMID:33517128
Abstract

Different conformational strains of tau have been implicated in the clinicopathological heterogeneity of tauopathies. In this study, we hypothesized that distinct strains are degraded in a different manner. Lithium, a drug for bipolar disorder, had previously been reported to reduce aggregation-prone protein content by promoting autophagy. Here, we assessed the effects of lithium on tau aggregates using different tauopathy brain seeds. SH-SY5Y cells were transfected with C-terminal tau fragment Tau-CTF24 (residues 243-441), and Alzheimer's disease (AD), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD) brain seeds were introduced. After 48-h lithium treatment, sarkosyl-insoluble fractions were prepared. Lithium treatment was found to reduce the amount of insoluble tau and p62, and increase LC3-II levels along with the number of autophagic vacuoles in AD-seeded cells. The effects were lower in case of CBD seeds, and comparable between PSP and AD seeds. An inhibitor of myo-inositol monophosphatase (IMPase) also demonstrated similar effects. Overall, the study suggested that aggregated tau protein is degraded by lithium-induced autophagy, influencing IMPase in a strain-specific manner.

摘要

不同构象的 tau 已被牵连到 tau 病的临床病理异质性中。在这项研究中,我们假设不同的构象以不同的方式降解。锂是一种用于治疗双相情感障碍的药物,先前曾被报道通过促进自噬来减少聚集倾向蛋白的含量。在这里,我们使用不同的 tau 病脑种子评估了锂对 tau 聚集物的影响。SH-SY5Y 细胞转染了 C 端 tau 片段 Tau-CTF24(残基 243-441),并引入了阿尔茨海默病(AD)、进行性核上性麻痹(PSP)和皮质基底节变性(CBD)脑种子。锂处理 48 小时后,制备了 Sarkosyl 不溶性级分。锂处理降低了 AD 种子细胞中不溶性 tau 和 p62 的量,并增加了 LC3-II 水平和自噬小体的数量。在 CBD 种子的情况下,效果较低,而在 PSP 和 AD 种子之间则相当。肌醇单磷酸酶(IMPase)的抑制剂也表现出类似的效果。总体而言,该研究表明,聚集的 tau 蛋白通过锂诱导的自噬降解,以特定于构象的方式影响 IMPase。

相似文献

1
Strain-specific clearance of seed-dependent tau aggregation by lithium-induced autophagy.锂诱导自噬特异性清除依赖种子的 tau 聚集物。
Biochem Biophys Res Commun. 2021 Mar 5;543:65-71. doi: 10.1016/j.bbrc.2020.12.113. Epub 2021 Jan 28.
2
Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy.人类 tau 病中的自噬和溶酶体缺陷:家族性阿尔茨海默病、皮质基底节变性和进行性核上性麻痹患者死后大脑的分析。
Acta Neuropathol Commun. 2016 Mar 2;4:22. doi: 10.1186/s40478-016-0292-9.
3
Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.糖原合酶激酶-3与阿尔茨海默病、皮克病、进行性核上性麻痹和皮质基底节变性中的神经元和胶质细胞过度磷酸化tau蛋白沉积有关。
Acta Neuropathol. 2002 Dec;104(6):583-91. doi: 10.1007/s00401-002-0587-8. Epub 2002 Jul 13.
4
Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration.抑制Rho激酶作为进行性核上性麻痹和皮质基底节变性的一种治疗方法。
J Neurosci. 2016 Jan 27;36(4):1316-23. doi: 10.1523/JNEUROSCI.2336-15.2016.
5
Human tauopathy-derived tau strains determine the substrates recruited for templated amplification.人源tau 病相关 tau 株决定了被招募用于模板扩增的底物。
Brain. 2021 Sep 4;144(8):2333-2348. doi: 10.1093/brain/awab091.
6
Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.使用新型构象选择性 Tau 抗体通过免疫组织化学检测 AD 和非 AD Tau 病中的 AD 特异性 Tau 病理学。
J Neuropathol Exp Neurol. 2018 Mar 1;77(3):216-228. doi: 10.1093/jnen/nly010.
7
Characterization of tau binding by gosuranemab.戈苏单抗对tau蛋白结合的特征分析。
Neurobiol Dis. 2020 Dec;146:105120. doi: 10.1016/j.nbd.2020.105120. Epub 2020 Sep 28.
8
Novel tau filament fold in corticobasal degeneration.新型 tau 丝在皮质基底节变性中的折叠。
Nature. 2020 Apr;580(7802):283-287. doi: 10.1038/s41586-020-2043-0. Epub 2020 Feb 12.
9
Chameleons and mimics: Progressive supranuclear palsy and corticobasal degeneration.变色龙与模仿者:进行性核上性麻痹与皮质基底节变性。
Neuropathology. 2020 Feb;40(1):57-67. doi: 10.1111/neup.12590. Epub 2019 Sep 12.
10
Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains.tau PET 示踪剂 PI2620、MK6240 和 RO948 在阿尔茨海默病、皮质基底节变性和进行性核上性麻痹脑中的鉴别结合。
Mol Psychiatry. 2023 Mar;28(3):1272-1283. doi: 10.1038/s41380-022-01875-2. Epub 2022 Nov 29.

引用本文的文献

1
Involvement of Autophagic Machinery in Neuropathogenesis: Targeting and Relevant Methods of Detection.自噬机制在神经病理发生中的作用:靶向作用及相关检测方法
Methods Mol Biol. 2025;2879:183-206. doi: 10.1007/7651_2024_516.
2
Proteostasis and neurodegeneration: a closer look at autophagy in Alzheimer's disease.蛋白质稳态与神经退行性变:深入探讨阿尔茨海默病中的自噬
Front Aging Neurosci. 2023 Nov 2;15:1281338. doi: 10.3389/fnagi.2023.1281338. eCollection 2023.
3
Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles.
用于阿尔茨海默病治疗的自噬药理学调节:机遇与障碍。
Acta Pharm Sin B. 2022 Apr;12(4):1688-1706. doi: 10.1016/j.apsb.2021.12.009. Epub 2021 Dec 18.
4
Current Status of Autophagy Enhancers in Metabolic Disorders and Other Diseases.自噬增强剂在代谢紊乱及其他疾病中的现状
Front Cell Dev Biol. 2022 Feb 14;10:811701. doi: 10.3389/fcell.2022.811701. eCollection 2022.
5
Endosomal-lysosomal dysfunctions in Alzheimer's disease: Pathogenesis and therapeutic interventions.阿尔茨海默病中的内体溶酶体功能障碍:发病机制和治疗干预。
Metab Brain Dis. 2021 Aug;36(6):1087-1100. doi: 10.1007/s11011-021-00737-0. Epub 2021 Apr 21.